Skip to main content
For professional inquiries, please contact us: reynolds_science_inquiries@rjrt.com
Reynolds Science REYNOLDS - A Better Tomorrow - Logo
  • Tobacco Harm Reduction
  • Smokeless Products
  • Our Science
    • Framework
    • Analytical Science
    • Pre-Clinical
    • Individual Health
    • Population Health
  • Let’s Connect
    • Conferences
  • Library
  • Tobacco Harm Reduction
  • Smokeless Products
  • Our Science
    • Framework
    • Analytical Science
    • Pre-Clinical
    • Individual Health
    • Population Health
  • Let’s Connect
    • Conferences
  • Library
For professional inquiries, please contact us: reynolds_science_inquiries@rjrt.com
science

Pre-Clinical

FPO

Sep 5th 2019

Optimization of Normal Human Bronchial Epithelial (NHBE) Cell 3D Cultures for in vitro Lung Model Studies

May 16th 2019

Genotoxicity evaluation of tobacco and nicotine delivery products: Part Two. In vitro micronucleus assay

Jan 16th 2019

Cigarette and ENDS preparations differentially regulate ion channels and mucociliary clearance in primary normal human bronchial 3D cultures

May 3rd 2017

AKR1C1 as a Biomarker for Differentiating the Biological Effects of Combustible from Non-Combustible Tobacco Products

Mar 1st 2017

Characterization and Application of the VITROCELL VC1 Smoke Exposure System and 3D EpiAirway Models for Toxicological and e-Cigarette Evaluations

Sep 14th 2015

Toxicological evaluation of smokeless tobacco: 2-year chronic toxicity and carcinogenicity feeding study in Wistar Han rats

Sep 1st 2014

Regulation of gene expression by tobacco product preparations in cultured human dermal fibroblasts

Apr 16th 2014

Combusted but not smokeless tobacco products cause DNA damage in oral cavity cells

Sep 17th 2012

Evaluation of cytotoxicity of different tobacco product preparations

  • Prev
  • 1
  • 2
  • 3
  • Next
Reynolds Science REYNOLDS - A Better Tomorrow - Logo

© 2026 RAISC.

This website is intended for scientists and policymakers. The material on this website is not provided for product advertising, promotional, or marketing purposes. We encourage persons interested in tobacco harm reduction to consider all points of view and sources of information. The Reynolds American organization does not make health claims regarding its companies’ brands. Nothing contained here should be misconstrued to the contrary. To the extent that third-party sources are referenced, the Reynolds American organization is not responsible for the content of referenced sources and the views expressed may not represent the views of the Reynolds American organization. No tobacco product is safe, all tobacco products containing nicotine are addictive. Underage persons should never use tobacco. Smokers who are concerned about their health should quit.

Reynolds American Inc. is the U.S. parent company of, among others, R. J. Reynolds Tobacco Company; Santa Fe Natural Tobacco Company, Inc.; American Snuff Company, LLC; R. J. Reynolds Vapor Company; Modoral Brands Inc.; RAI Services Company; and Reynolds Marketing Services Company. All subsidiaries operate and conduct separate, distinct businesses. References to “Reynolds,” “the group,” “the company,” “the organization,” “we,” “us,” and “our” are simply for convenience and may be used to refer to Reynolds American Inc. and/or one of its independent subsidiary operating companies, collectively or individually, and are not intended to imply or suggest that the subsidiaries’ businesses are operated other than as separate, distinct businesses. Activities among affiliate companies are covered through intercompany services agreements with arm's-length terms and conditions.

  • Terms of Use
  • Member of the Global BAT Group